600535 logo

Tasly Pharmaceutical Group Co., Ltd Stock Price

SHSE:600535 Community·CN¥20.6b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

600535 Share Price Performance

CN¥13.82
-1.22 (-8.11%)
CN¥13.82
-1.22 (-8.11%)
Price CN¥13.82

600535 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Very undervalued with flawless balance sheet and pays a dividend.

1 Risk
5 Rewards

Tasly Pharmaceutical Group Co., Ltd Key Details

CN¥8.2b

Revenue

CN¥0

Cost of Revenue

CN¥8.2b

Gross Profit

CN¥7.1b

Other Expenses

CN¥1.1b

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
Mar 20, 2026
0.74
100.00%
13.42%
6.9%
View Full Analysis

About 600535

Founded
1994
Employees
10958
CEO
Jin Yong Cai
WebsiteView website
www.taslypharma.com

Tasly Pharmaceutical Group Co., Ltd researches, develops, manufactures, and sells medicines and related pharmaceuticals in China and internationally. The company provides prescription drugs covering various therapeutic areas, including cardiovascular and cerebrovascular, hepato-biliary-pancreatic, respiratory system, diabetes, tumor immunity, gastrointestinal disease, gynecological, rheumatism, soothe the nerves, pruritus, and andrological areas, as well as over-the-counter drugs. Tasly Pharmaceutical Group Co., Ltd was founded in 1994 and is based in Tianjin, China.

Recent 600535 News & Updates

Recent updates

No updates